Related Experiment Video
Updated: Oct 13, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic
Yan-Li Yang1, Zi-Jian Xiang2, Jing-Hua Yang2
1Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract:
Background: Invasive fungal infections (IFI) is an important contributing factor in morbidity and mortality of immunocompromised and critically ill patients. Although the therapeutic effects of these drugs on IFI have been well documented, the long-term use of antifungal agents has raised concerns about drug tolerability and treatment-related toxicity risks. Methods: We searched articles published before June 30, 2020 in four electronic databases: Web of Science, Cochrane Library, embase and PubMed. Results: 66 trials were determined to meet our inclusion criteria, providing data on 18,230 participants. We sorted out 23 AEs by system organ classes and six laboratory AEs, 13 of these were used to construct 13 network meta-analyses. Compared with LAmB, anidulafungin, caspofungin, micafungin, fluconazole, and posaconazole had a significantly low incidence of discontinuation of therapy due to AEs (OR = 0.24 (0.09,0.65), 0.24 (0.13,0.43), 0.32 (0.19,0.52), 0.38 (0.23,0.62) and 0.35 (0.17,0.69), respectively). Conclusion: We found that echinocandins are the most tolerated antifungal agents with high safety. The AEs of triazole drugs are mainly concentrated on the increase in liver enzymes, nervous system disorders, especially visual disorders, gastrointestinal disorders, and cardiac diseases. LAmB is the least tolerated and has the most abundant AEs.
Insights
Echinocandins demonstrate superior tolerability and safety compared to other antifungal agents for invasive fungal infections (IFI). Amphotericin B lipid complex (LAmB) exhibits the most adverse events, while triazoles present specific risks like liver and visual disturbances.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Invasive fungal infections (IFI) significantly contribute to morbidity and mortality in immunocompromised and critically ill patients.
- Long-term antifungal therapy raises concerns regarding drug tolerability and treatment-related toxicity.
- Understanding comparative safety profiles is crucial for optimizing IFI management.
Purpose of the Study:
- To systematically compare the safety and tolerability of various antifungal agents used for invasive fungal infections.
- To identify antifungal drugs with the lowest incidence of adverse events and treatment discontinuation.
- To inform clinical decision-making by highlighting the risk-benefit profiles of different antifungal treatments.
Main Methods:
- A comprehensive literature search was conducted across four major electronic databases (Web of Science, Cochrane Library, Embase, PubMed) up to June 30, 2020.
- Inclusion criteria identified 66 trials involving 18,230 participants.
- Network meta-analyses were performed on 13 specific adverse events (AEs) categorized by system organ classes and laboratory findings.
Main Results:
- Echinocandins (anidulafungin, caspofungin, micafungin) showed significantly lower rates of therapy discontinuation due to AEs compared to liposomal amphotericin B (LAmB).
- Triazole drugs (fluconazole, posaconazole) also demonstrated a lower incidence of AE-related discontinuation versus LAmB.
- LAmB was associated with the highest number and broadest range of adverse events, indicating the lowest tolerability.
Conclusions:
- Echinocandin antifungals are the most well-tolerated and safest options for treating invasive fungal infections.
- Triazole-associated adverse events primarily involve hepatic, neurological (especially visual), gastrointestinal, and cardiac systems.
- LAmB presents the most significant tolerability challenges and the most extensive spectrum of adverse events among the evaluated antifungal agents.
More Related Videos
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antimicrobial Effectiveness
Therapeutic Drug Monitoring: Affecting Factors
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

